Sandra Rojas-Caro - Jan 24, 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Chief Medical Officer
Signature
/s/ Dietrich Stephan, as attorney-in-fact for Sandra Rojas-Caro
Stock symbol
NBSE
Transactions as of
Jan 24, 2022
Transactions value $
$0
Form type
4
Date filed
1/25/2022, 01:00 PM
Previous filing
May 25, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Employee stock option (right to buy) Award $0 +44.6K $0.00 44.6K Jan 24, 2022 Common stock 44.6K $1.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the total shares shall vest on the first anniversary of January 24, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date.

Remarks:

The power of attorney under which this form was signed is on file with the U.S. Securities and Exchange Commission.